Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee
Double-blinde, randomised, non-inferiority study, comparing two different SYSADOA observation in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee.